10.04.2019 • NewsCarlyleCepsaElaine Burridge

Carlyle Takes Minority Stake in Cepsa

Carlyle Takes Minority Stake in Cepsa (c) Mubadala
Carlyle Takes Minority Stake in Cepsa (c) Mubadala

Funds associated with US investment group Carlyle have agreed to take a "significant" minority interest in Spanish oil & gas and chemicals company Cepsa from Abu Dhabi-based Mubadala Investment Company.

Carlyle will take a share ranging between 30% and 40%, with Mubadala remaining Cepsa’s majority shareholder. Mubadala said final stakes will be confirmed once the transaction closes, which is expected by the end of 2019, subject to the usual regulatory approvals. The companies did not disclose financial terms.

Mubadala said the agreement marks the successful conclusion of a dual-track process through a public offering and private placement to bring in new partners as part of its portfolio management strategy.

Marcel Van Poecke, head of Carlyle International Energy Partners, said Cepsa offers strong potential and future opportunities in the global energy sector.

Cepsa is also the global leader in the production of linear alkyl benzene (LAB), as well as the world's second largest producer of phenol and acetone. The Madrid-headquartered group is currently developing a 150,000 t/y LAB plant at Abu Dhabi National Oil Company's (ADNOC) complex in Ruwais, UAE, as well as upgrading its own plant in San Roque, Cadiz, Spain. The latter project, which will expand capacity by 50,000 t/y, is due online in the first half of 2020.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.